These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9719729)

  • 21. Comparison of ondansetron, dexamethasone, ondansetron plus dexamethasone and placebo in the prevention of nausea and vomiting after laparoscopic tubal ligation.
    Biswas BN; Rudra A; Mandal SK
    J Indian Med Assoc; 2003 Nov; 101(11):638, 640, 642. PubMed ID: 15198411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a single-dose ondansetron for preventing post-operative nausea and vomiting after laparoscopic cholecystectomy with sevoflurane and remifentanil infusion anaesthesia.
    Paventi S; Santevecchi A; Ranieri R
    Eur Rev Med Pharmacol Sci; 2001; 5(2):59-63. PubMed ID: 11863320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of delayed emesis caused by chemotherapy.
    Harmon D; O'Brien B
    N Engl J Med; 2000 Sep; 343(12):889; author reply 889-90. PubMed ID: 11001695
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of radiation-induced nausea and vomiting.
    Abdelsayed GG
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):34-6. PubMed ID: 17379085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acupuncture to reduce nausea during chemotherapy treatment of rheumatic diseases.
    Josefson A; Kreuter M
    Rheumatology (Oxford); 2003 Oct; 42(10):1149-54. PubMed ID: 12777644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical evaluation of ondansetron suppository].
    Kobayashi F; Yamanouchi T; Shimizu T; Sato H; Adachi I; Sakamoto T; Fujimaki M; Horikoshi I
    Gan To Kagaku Ryoho; 1997 Mar; 24(5):625-7. PubMed ID: 9087300
    [No Abstract]   [Full Text] [Related]  

  • 27. The anti-emetic efficacy of a combination of ondansetron and droperidol.
    Chan MT; Gin T
    Anaesthesia; 1998 Apr; 53(4):413. PubMed ID: 9613323
    [No Abstract]   [Full Text] [Related]  

  • 28. Correct choice of anti-emetic.
    Moyle JT
    Anaesthesia; 1997 Nov; 52(11):1117. PubMed ID: 9404183
    [No Abstract]   [Full Text] [Related]  

  • 29. [Granisetron (per os) compared with ondansetron (per os) in the prevention of nausea and vomiting induced by mildly emetogenic chemotherapies. Groupe de Recherches en Cancerologie du Nord].
    Huc P; Block S; Carlier D; Darloy F; Bonneterre ME; Bleuse JP; Fournier C; Bonneterre J
    Bull Cancer; 1998 Jun; 85(6):562-8. PubMed ID: 9752283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First choice for radiation-induced nausea and vomiting--the efficacy and safety of granisetron.
    Goldsmith B
    Acta Oncol; 2004 Sep; 43 Suppl 15():19-22. PubMed ID: 15370626
    [No Abstract]   [Full Text] [Related]  

  • 31. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting.
    Gan TJ; Sinha AC; Kovac AL; Jones RK; Cohen SA; Battikha JP; Deutsch JS; Pergolizzi JV; ; Glass PS
    Anesth Analg; 2009 May; 108(5):1498-504. PubMed ID: 19372328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of the menstrual cycle and ondansetron on postoperative nausea and vomiting.
    Bacić A; Rumboldt Z; Gluncić I; Buklijas J
    Int J Clin Pharmacol Res; 1998; 18(4):153-8. PubMed ID: 10052024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevention of postoperative nausea and vomiting using a combination of ondansetron and droperidol.
    Kessell G
    Anaesthesia; 1997 Feb; 52(2):191. PubMed ID: 9059130
    [No Abstract]   [Full Text] [Related]  

  • 34. Granisetron vs ondansetron for prevention of nausea and vomiting in hematopoietic stem cell transplant patients: results of a prospective, double-blind, randomized trial.
    Walsh T; Morris AK; Holle LM; Callander N; Bradshaw P; Valley AW; Clark G; Freytes CO
    Bone Marrow Transplant; 2004 Dec; 34(11):963-8. PubMed ID: 15489869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness analysis of oral ondansetron and prochlorperazine for preventing nausea and vomiting after moderately emetogenic chemotherapy.
    Kwong WJ; Parasuraman TV
    Pharm Pract Manag Q; 1999 Apr; 19(1):28-41. PubMed ID: 10351607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ramosetron for the prevention of nausea and vomiting during 5-fluorouracil-based chemoradiotherapy for pancreatico-biliary cancer.
    Kim K; Chie EK; Jang JY; Kim SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Jpn J Clin Oncol; 2009 Feb; 39(2):111-5. PubMed ID: 19060294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Placebo controlled trials of ondansetron for postoperative nausea and vomiting.
    Palmer JB; Gibbs TG; Taylor CM
    BMJ; 1996 Jan; 312(7024):183. PubMed ID: 8563554
    [No Abstract]   [Full Text] [Related]  

  • 38. Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
    Rubenstein EB
    Clin Adv Hematol Oncol; 2004 May; 2(5):284-9. PubMed ID: 16163194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-analysis: ondansetron for vomiting in acute gastroenteritis in children.
    Fedorowicz Z; Alhashimi D; Alhashimi H
    Aliment Pharmacol Ther; 2007 Oct; 26(7):1086; author reply 1087. PubMed ID: 17877518
    [No Abstract]   [Full Text] [Related]  

  • 40. [Novel pharmacologic form of ondansetron (Zofran)--lingual tablets in the prevention of cytostatic chemotherapy-induced loss of appetite, nausea and vomiting].
    Gershanovich ML; Beresneva IA; Makhnova EV
    Vopr Onkol; 2003; 49(4):505-9. PubMed ID: 14569947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.